Trials / Completed
CompletedNCT02728193
Standard Treatments of Very-early Stage Hepatocellular Carcinoma
The Research on Standard Treatments of Very-early Stage Hepatocellular Carcinoma: a Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Eastern Hepatobiliary Surgery Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of our study was to elucidate the difference in the rates of complication, hospitalization days, medical expenses, MRI showed that the degree of tumor necrosis, and overall survival rates of the therapies between PEI, MVA and RFA, and make the standard for minimally invasive treatment of very early stage HCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | RFA | |
| PROCEDURE | MWV | |
| PROCEDURE | PEI | Percutaneous ethanol injection |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-12-01
- Completion
- 2015-12-01
- First posted
- 2016-04-05
- Last updated
- 2016-04-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02728193. Inclusion in this directory is not an endorsement.